3
Announcements
Trials
Browse
Landscape
Phase
Phase 1
1
Status
Terminated
1
Sponsor Class
OTHER
1
Study Type
Interventional
1
Sponsor
Cancer Type
Other hematologic neoplasm
1
Myeloid
1
Classical hematology
1
Conditions
Leukemia
2
Preleukemia
1
Myelodysplastic Syndromes
1
Leukemia, Myeloid, Acute
1
Hematologic Diseases
1
Cytopenia
1
Bone Marrow Diseases
1
Anemia
1
Interventions
Melphalan
4
fludarabine
3
fludarabine phosphate
2
Whole-Body Irradiation
2
Tacrolimus
2
Peripheral Blood Stem Cell Transplantation
2
Patient Reported Outcome Measures
2
Mycophenolic Acid
2
Mesna
2
Cyclophosphamide
2
Busulfan
2
Bone Marrow Transplantation
2
Alemtuzumab
2
venetoclax
1
spartalizumab
1
sabatolimab
1
ruxolitinib
1
lintuzumab
1
filanesib
1
Stem Cell Transplantation
1
Sertraline
1
Sampling Studies
1
Metformin
1
Lenalidomide
1
Decitabine
1
Clofarabine
1
CPI-0610
1
Biopsy
1
Azacitidine
1
Date Range
30 days
90 days
1 year
All
Options
Has results
Has announcements
Clinical Trials
1 trials
Recent
Start date
Enrollment
Preleukemia
×
Sertraline
×
Other hematologic neoplasm
×
Clear all
NCT02452983
2022-06-02
SS1
Baylor College of Medicine
Phase 1
Terminated
14 enrolled